Flagship, launching first
Non-Invasive Prenatal Sickle Cell Screening
In development with our laboratory partner
A maternal blood sample, analysed by our specialist laboratory partner, can assess whether a baby is at risk of sickle cell disease and related haemoglobin disorders, without any procedure that reaches the baby.
This is a screening test, not a diagnosis.
Guidance
Genetic Counselling
Forming part of the launch service
Guidance before and after testing, with inheritance risk explained plainly and decisions supported without pressure.
You will have time to ask questions, consider your options, and decide in your own time.
Support first. Testing is always your choice.
Planned
Couples’ Genotype and Carrier Screening
In development
Confirming both parents’ genotypes, including AA, AS, AC and other variants, so risk is understood before pregnancy or early in pregnancy.
Confirmation matters, because an old or incorrect genotype report can change the picture completely.
This is a screening test, not a diagnosis.
Planned
Core Prenatal Screen
Planned
Chromosomal screening from a maternal blood sample, covering:
- Trisomy 21 (Down syndrome)
- Trisomy 18 (Edwards syndrome)
- Trisomy 13 (Patau syndrome)
It can also tell the baby’s sex, if you wish to know.
This is a screening test, not a diagnosis.
Planned
Sex Chromosome Screening
Planned
An add-on to the Core Prenatal Screen, covering the sex chromosomes.
It is taken from the same blood sample, at the same time, so there is no second draw and nothing extra asked of you.
This is a screening test, not a diagnosis.
Planned
Non-Invasive Prenatal Paternity Test
Planned
Paternity established before birth, from the mother’s blood and a sample from the alleged father.
It is arranged only with the mother’s written consent, and the result is delivered to the mother alone.
This is a screening test, not a diagnosis. The mother’s written consent is always required first.